Regulators approve Ubichem for commercial cGMP API production
Advertisement
Ubichem Research has successfully completed its first regulatory audit and is now approved by OGYI (Hungarian National Institute for Pharmacy) for the commercial supply of cGMP active pharmaceutical ingredients (APIs). Reciprocal agreements mean that this approval is effective throughout the EU.
"This is a fantastic achievement, a real testament to the skill of our dedicated team in Budapest. Having been manufacturing quantities of API for clinical trial, this approval represents a major step forward in our business and is a clear demonstration of our commitment to quality - allowing us to support our pharma and biotech clients all the way from candidate nomination to market."
A $1-million investment in new and upgraded analytical, development and production capacity is already underway at the company's facilities. This is expected to be completed during 2007.
Most read news
Organizations
Other news from the department manufacturing
These products might interest you
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Shimadzu Deutschland GmbH - Duisburg, Germany
BASF with solid start to the year
Global Polyester Market to Reach Nearly 40 Million Tons - China is the largest producer of polyester
NRL scientists produce carbon nanotubes using commercially available polymeric resins
BASF and three top European universities team up on functional materials research - Goal: innovation in multi-materials and systems
Bayer MaterialScience acquires remaining shares in the systems house joint venture Baulé
KSB SE & Co. KGaA - Frankenthal, Germany